Divalproex Sodium

CAS 76584-70-8 14 current records 6 historicalSmall Molecule

Who holds supplier records for Divalproex Sodium? 14 organisations hold a current record for Divalproex Sodium: an active US FDA Type II Drug Master File. A further 6 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (11), Netherlands (1), France (1) and Taiwan (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Divalproex Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/divalproex-sodium

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    11 of the 14 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Divalproex Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Divalproex Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (6)

Organisations whose Type II DMFs for Divalproex Sodium are no longer active. These show a past filing, not current supply.

Show all 6 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Divalproex Sodium is a medication primarily used to treat seizure disorders, bipolar disorder, and to prevent migraine headaches. It is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship.

Chemical identity

IUPAC name
sodium;hydron;bis(2-propylpentanoate)
Canonical SMILES
[H+].CCCC(CCC)C(=O)[O-].CCCC(CCC)C(=O)[O-].[Na+]
InChIKey
MSRILKIQRXUYCT-UHFFFAOYSA-M
Synonyms
Depakote API, abbott 50711, abbott-50711, depakote, divalproex, semisodium valproate, valproate semisodium, valproic acid sodium salt (2:1)

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Anti-epileptic Agent; Mood Stabilizer
Physiologic effect
Decreased Central Nervous System Disorganized Electrical Activity

Therapeutic areas

NeurologyPsychiatry

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Divalproex Sodium?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Divalproex Sodium: APITORIA PHARMA PRIVATE LTD (India), Sun Pharmaceutical Industries Limited (India), ANJAN DRUG PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), HARMAN FINOCHEM LTD (India), Hetero Drugs Limited (India), KATWIJK CHEMIE BV (Netherlands) and MAITHRI DRUGS PRIVATE LTD (India), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Divalproex Sodium Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 29097, 41871), Sun Pharmaceutical Industries Limited (DMF 19884, 38911), ANJAN DRUG PRIVATE LTD (DMF 20036), Dr. Reddy's Laboratories Ltd. (DMF 19871), HARMAN FINOCHEM LTD (DMF 21532), Hetero Drugs Limited (DMF 31437), KATWIJK CHEMIE BV (DMF 16312) and MAITHRI DRUGS PRIVATE LTD (DMF 34440) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Divalproex Sodium records mean?

6 organisations have only inactive Type II DMFs for Divalproex Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Divalproex Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Divalproex Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.